Funding for this research was provided by:
National Cancer Institute, National Institutes of Health (R37CA240707)
Article History
Received: 13 May 2021
Accepted: 25 May 2021
First Online: 9 June 2021
Declarations
:
: The presented study protocol received approval by the Institutional Review Board (IRB) of University Hospitals (UH) Medical Center on August 26, 2019 (Study 20190943). The IRB approves all modifications to the study protocol prior to their implementation. Participants must provide written informed consent to be included in the study. The sponsor for this study is the Case Comprehensive Cancer Center, 10900 Euclid Ave., Cleveland, Ohio, US, 44106 − 7285, telephone 1-216-368-1122.
: Not Applicable; the manuscript does not contain data from any individual person.
: The authors declare that they have no competing interests.